VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Nanotech Security Corp. (TSXV:NTS) (OTCQX:NTSFF), (“Nanotech” or the “Company”), a leading innovator in the design and supply of advanced security products for the anti-counterfeiting market, today released its financial results for the fourth quarter and year ended September 30, 2017. Unless otherwise stated, all dollar amounts are expressed in Canadian dollars.
Highlights from 2017 Continuing Operations
- Revenue increased 154% to $7.3 million compared to the same period last year. Paid development contracts and optical thin film (“OTF”) deliveries from our Thurso facility accounted for the year over year revenue growth.
- Gross margins improved to 81%, up from 69% in the same period last year. Gross margins continue to reflect strong margins from both development contracts and OTF deliveries.
- Annual Adjusted EBITDA(1) reached $1.2 million. Strong revenues and gross margins resulted in Nanotech achieving its first full year of positive Adjusted EBITDA, a notable milestone and improvement from the $3.6 million negative Adjusted EBITDA reported for the same period last year.
- Successfully closed $13.3 million private bought deal financing. On May 18, 2017, the Company closed a $13.3 million financing. Part of the proceeds were used to repay $1.4 million of convertible debentures and retire a $3.0 million secured note.
- Cash balance of $10.9 million at quarter-end. The Company finished the year with a strong cash position and no debt or warrants outstanding.
Recent Developments
- Divestiture of non-core business. On September 21, 2017, Company Directors decided that selling the Company’s subsidiary, Tactical Technologies Inc. (“Tactical”), was in the Company’s long-term interest. The Company is actively pursuing potential purchasers and has engaged a business broker to pursue interested third parties. At September 30, 2017, Tactical was classified as a separate disposal group held for sale and as a discontinued operation. Accordingly, the Company’s comparative consolidated statements of operation have been restated to exclude the discontinued operations. The Company has restructured Tactical’s operations and it currently operates with five employees with a limited cash burn. At September 30, 2017, Tactical had $216,225 in assets held for sale and $200,226 in liabilities. It is expected that Tactical will either be sold or wound down over the next six months.
- Paid development contracts are progressing well. The Company currently derives a significant portion of its revenue from paid development projects with major issuing authorities. During the year, the Company announced a development contract for up to $30.0 million over a period of up to five years. These development activities incorporate both nano-optic and OTF technologies and are focused on developing authentication features for future banknotes. All projects are progressing well and the Company continues to see development revenue as a significant growth area for the business.
- Tax stamps and commercial markets. The Company’s nano-optic images have now become qualified with a customer in India that is currently supplying several billion holographic tax stamps to the Indian government. Management is working with this customer to transition the government from traditional holographic images to licensing Nanotech nano-optic images.
- Commercial applications. The Indian market has presented several other long-term opportunities beyond tax stamps. The Company is working with the same tax stamp partner to pursue the broader foil packaging market. Outside of India, the Company is pursuing opportunities in the luxury brand, cosmetics and pharmaceutical markets.
- Thurso OTF opportunities. The Company continues to deliver OTF from its Thurso facility. The Company also sees new opportunities to potentially work on new denominations within our existing customer base.
- Asian OTF opportunities. The Company continues to work with its European production partner Hueck Folien to become qualified to deliver volume OTF to a specific Asian customer. Overall, management remains optimistic that there is strong customer demand for OTF and that over time our production partner, Hueck Folien will be successful in demonstrating its ability to produce colour-shifting OTF. At this point in time, management cannot specify when or if volume shipments will commence to this customer.
Doug Blakeway, Nanotech’s Chairman and CEO, commented, “Fiscal year 2017 was, by all accounts, a tremendous year for Nanotech Security. Growing our revenues by 154% and achieving $1.2 million of positive Adjusted EBITDA far exceeds our goals for the year. With over $10.9 million in cash and no debt, the Company is well positioned to continue our growth in 2018.”
Select Financial Information
All results are reported in Canadian dollars and are prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").
| Three months ended September 30, | Years ended September 30, | ||||||||||||||||
| % | % | ||||||||||||||||
| 2017 | 2016 | Change | 2017 | 2016 | Change | ||||||||||||
| Revenue | $ | 2,661,660 | $ | 1,177,366 | 126 | % | $ | 7,343,791 | $ | 2,888,896 | 154 | % | |||||
| Gross profit | 2,242,745 | 924,237 | 143 | % | 5,914,420 | 2,004,764 | 195 | % | |||||||||
| Gross profit % | 84 | % | 79 | % | 81 | % | 69 | % | |||||||||
| Adjusted EBITDA(1) | 1,132,249 | (444,278 | ) | 355 | % | 1,168,222 | (3,648,411 | ) | 132 | % | |||||||
| Net loss | (300,694 | ) | (1,676,026 | ) | (82 | %) | (4,754,132 | ) | (7,829,805 | ) | (39 | %) | |||||
| Net loss per share Basic and diluted | 0.00 | (0.03 | ) | (0.08 | ) | (0.15 | ) | ||||||||||
| Weighted average number of common shares Basic and diluted | 68,107,758 | 53,686,940 | 59,056,353 | 53,524,646 | |||||||||||||
(1)Adjusted EBITDA is a non-IFRS measure as described in the Non-IFRS Financial Measures section of this News Release.
| Financial Position as at September 30, | 2017 | 2016 | % Change | ||||
| Cash | $ | 10,883,919 | $ | 3,312,691 | 229 | % | |
| Total debt | - | 6,595,142 | (100 | %) | |||
| $ | 10,883,919 | $ | (3,282,451 | ) | 432 | % | |
| Total assets | $ | 30,059,624 | $ | 24,511,586 | 23 | % | |
| Total liabilities | 1,860,086 | 8,089,503 | (77 | %) | |||
| Total equity | 28,199,538 | 16,422,083 | 72 | % | |||
Revenue
Revenues for the three months ended September 30, 2017 increased by $1,484,294 or 126% to $2,661,660, compared to $1,177,366 in the same period last year. Revenues for the year ended September 30, 2017 increased by $4,454,895 or 154% to $7,343,791, compared to $2,888,896 in the same period last year.
Revenue growth was primarily due to increased revenue from paid development contracts and an increase in OTF revenue from our Thurso facility. During the year, the Company disclosed a development contract for up to $30.0 million over a period of up to five years. These development activities incorporate both nano-optic and OTF technologies and are focused on developing authentication features for future banknotes.
Gross Margin
Gross margin for the three months ended September 30, 2017 increased by $1,318,508 or 143% to $2,242,745, compared to $924,237 in the same period last year. Overall, the gross margin percentage improved to 84% for the three months ended September 30, 2017, an increase from 79% in the same period last year. Gross margins continue to reflect strong margins from both development contracts and OTF deliveries.
Gross margin for the year ended September 30, 2017 increased by $3,909,656 or 195% to $5,914,420, compared to $2,004,764 in the same period last year. Overall, the gross margin percentage improved to 81% for the year ended September 30, 2017, an increase from 69% in the same period last year. Gross margins continue to reflect strong margins both development contracts and OTF deliveries.
Research and Development
Research and development expenditures for the three months ended September 30, 2017 decreased by $172,409 or 37% to $296,124, compared to $468,533 in the same period last year due to a larger portion of salaries and other expenses being allocated to cost of sales for increased development projects activities.
Research and development expenditures for the year ended September 30, 2017 decreased by $521,278 or 26% to $1,475,437, compared to $1,996,715 in the same period last year, again due to a larger portion of salaries and other expenses being allocated to cost of sales for increased development projects activities.
General and Administration
General and administration expenditures for the three months ended September 30, 2017 were $444,859, a decrease of $147,680 or 25% compared to $592,539 in the same period last year which reflects an increase in salaries, offset by a decrease in office and overhead expenditures.
General and administration expenditures for the year ended September 30, 2017 were $2,308,846, an increase of $1,478, consistent with the same period last year.
Sales and Marketing
Sales and marketing expenditures for the three months ended September 30, 2017 were $595,165, an increase of $79,534 or 15% compared to $515,631 in the same period last year which reflects an increase in salaries, offset by a reduction in travel and marketing expenses. The sales and marketing activities continue to focus on developing business within the banknote, tax stamp and commercial markets.
Sales and marketing expenditures for the year ended September 30, 2017 were $2,043,514, a decrease of $35,098 or 2% compared to $2,078,612 in the same period last year. The decrease mainly relates to a reduction in travel and marketing expenses.
Depreciation and Amortization
Depreciation and amortization included in operating expenditures for the three months ended September 30, 2017 was $678,313, compared to $714,131 in the same period last year. Depreciation included in cost of sales for the three months ended September 30, 2017 was $50,717 compared to $54,635 in the same period last year. The reduction in depreciation and amortization expenditures reflect the Company’s declining balance depreciation policy and fewer fixed asset additions.
Depreciation and amortization included in operating expenditures for the year ended September 30, 2017 was $2,755,882, compared to $3,010,263 in the same period last year. Depreciation included in cost of sales for the year ended September 30, 2017 was $160,401 compared to $67,734 for the same period last year. The reduction in depreciation and amortization expenditures also reflects the Company’s declining balance depreciation policy and fewer fixed asset additions.
As of September 30, 2017, the Company has fully amortized its intangible assets, which will result in a reduction in annual amortization of $1,361,239 going forward.
Other Expenses
Other expenses for the three months ended September 30, 2017 were $101,701, a decrease of $97,459 compared to $199,160 in the same period last year. The decrease includes a reduction in net interest expense of $234,923 reflecting the repayment of both the convertible debt, long-term debt and having more cash on hand. This improvement was partially offset by a foreign exchange loss of $112,974 during the period compared to a $24,490 gain in the same period last year.
Other expenses for the year ended September 30, 2017 were $1,184,594, an increase of $751,081 compared to $433,513 in the same period last year. The 2017 results contain $1,014,779 of interest expense including, $589,858 of accretion that was a result of the Company’s decision to repay the convertible debentures and an increase in foreign exchange loss during the year.
Adjusted EBITDA
Adjusted EBITDA for the three months ended September 30, 2017 was $1,132,249, compared to negative $444,278 during the same period last year. Adjusted EBITDA for the year ended September 30, 2017 was $1,168,222, compared to negative $3,648,411 during the same period last year. The improvement reflects an increase in revenues, reduced expenses, and higher margins.
Net Loss
Net loss for the three months ended September 30, 2017 was $300,694, compared to $1,676,026 during the same period last year. Net loss for the year ended September 30, 2017 was $4,754,132, compared to $7,829,805 during the same period last year. The decrease in net loss also reflects an increase in revenues, higher margins, and lower expenses.
Capital Resources
The Company ended the year with $10,883,919 in cash and cash equivalents, up from $3,312,691 at September 30, 2016. On May 18, 2017, the Company completed a bought deal private placement with a syndicate of underwriters whereby a total of 11,586,870 common shares of the Company were issued at a price of $1.15 per share, for total gross proceeds of $13,324,901.
During the year, the Company had convertible debentures outstanding with a face value amounting to $4,185,000 with a maturity date of May 31, 2018. The convertible debentures accrued interest at a rate of 12% per annum payable quarterly in arrears and were convertible into common shares of the Company at a price of $1.25 per share. On May 18, 2017, the Company provided notice to the debenture holders of the Company’s intention to repay the convertible debentures on June 21, 2017. Most debenture holders elected to convert their debentures into common shares at $1.25 per share. As a result, the Company issued 2,252,000 common shares valued at $2,815,000. The remaining $1,370,000 was repaid.
The Company also had a note payable that was fully secured against the assets of the Company and required interest payments at a fixed rate of 4% per annum, with payment of the principal due on September 16, 2017. On August 21, 2017, the note payable was repaid in full and all security released.
The Company had approximately $2.6 million in commitments as of September 30, 2017. Management has reviewed its projected funding requirements and expects that, through the generation and collection of revenues, the Company will continue to maintain sufficient liquidity through September 30, 2018.
Non-IFRS Financial Measures
In addition to results reported in accordance with IFRS, the Company discloses Adjusted EBITDA as a supplemental indicator of its financial performance.
The Company defines Adjusted EBITDA as net loss excluding the impact of interest and financing costs (net of interest income), income taxes, depreciation and amortization, share-based compensation, loss from discontinued operations, and foreign exchange (gain) loss. The Company believes Adjusted EBITDA is a useful measure because it provides information to management about the operating and financial performance of the Company and its ability to generate operating cash flow to fund future working capital needs, and fund future growth. Adjusted EBITDA may also be used by investors and analysts for the purpose of valuing the Company.
Readers are cautioned that these non-IFRS definitions are not recognized measures under IFRS, do not have standardized meanings prescribed by IFRS, and should not be construed to be alternatives to net earnings determined in accordance with IFRS or as indicators of performance or liquidity or cash flows. The Company’s method of calculating these measures may differ from methods used by other entities and accordingly our measures may not be comparable to similarly titled measures used by other entities or in other jurisdictions. The Company uses these measures because it believes they provide useful information to both management and investors with respect to the operating and financial performance of the Company.
| Three months ended | Years ended | |||||||||||
| September 30, | September 30, | |||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||
| Net loss | $ | (300,694 | ) | $ | (1,676,026 | ) | $ | (4,754,132 | ) | $ | (7,829,805 | ) |
| Finance (income) expense | (11,273 | ) | 223,650 | 1,014,779 | 354,720 | |||||||
| Foreign exchange (gain) loss | 112,974 | (24,490 | ) | 169,815 | 78,793 | |||||||
| Deferred income tax recovery | - | - | - | (162,797 | ) | |||||||
| Depreciation and amortization | 727,430 | 768,766 | 2,916,283 | 3,077,997 | ||||||||
| Share-based compensation | 176,535 | 153,553 | 921,198 | 661,786 | ||||||||
| Loss from discontinued operations | 427,277 | 110,269 | 900,279 | 170,895 | ||||||||
| Adjusted EBITDA | $ | 1,132,249 | $ | (444,278 | ) | $ | 1,168,222 | $ | (3,648,411 | ) | ||
The Company’s MD&A for the year ended September 30, 2017 provides additional information regarding these financial metrics and the specified items affecting the comparability of net earnings.
ADDITIONAL INFORMATION
Outlook
Nanotech is a leader in next-generation anti-counterfeiting products. These products have brand protection and enhancement applications across a wide range of markets including banknotes, secure government documents, commercial branding, and the pharmaceutical industry. Nanotech is initially focusing its efforts on the banknote market due to its strong margins and established customer base. With the recent signing of the $30 million development contract, the Company is focusing on further developing business with its established customer base and, as a result, is well positioned to expand its authentication development contract revenue and other nano-optic and OTF opportunities in the years ahead.
In 2017, management established goals to double its revenue and make significant progress towards becoming cash flow positive. Management is pleased that it has exceeded both goals for 2017 with revenue growth of 154% and achieving positive Adjusted EBITDA of $1,168,222 for the year. In addition, the Company has developed many significant market opportunities in the banknote, tax stamp and commercial markets.
Looking ahead to 2018, the Company is well positioned financially to pursue these opportunities. With a strong balance sheet including $10,883,919 in cash and no debt, management has established the following goals for 2018:
- Grow revenues by 20% to 40% (which excludes the potential Asian OTF order);
- Begin to collect licensing revenue from the tax stamp and commercial markets;
- Maintain a strong focus on earnings with a target of 15% to 20% Adjusted EBITDA margin;
- Continue to pursue a volume OTF partnering opportunity with Hueck Folien for Asian banknotes;
- Invest in several key marketing hires to ensure internal resources are in place to develop the products, sales channels, and marketing materials necessary to penetrate commercial markets; and
- Continue to open new corporate development opportunities by partnering with established companies to enable Nanotech to enter new markets.
Achieving these results is not certain and involves known and unknown risks that may cause actual results to differ materially from this goal. These risks and uncertainties include, among other things, risks related to uncertainty of amount and timing of purchase orders, the ability of Hueck Folien to successfully deliver volume production, and our ability to expand our development revenue. These and other risk factors are further discussed under the “Business Risks and Uncertainties” segment of the September 30, 2017 Management’s Discussion and Analysis.
| Nanotech Security Corp. | ||||||||||||
| Condensed Consolidated Statements of Operations and Comprehensive Loss | ||||||||||||
| Years ended September 30, 2017 and 2016 | ||||||||||||
| (In Canadian dollars) | ||||||||||||
| Three months ended | Years ended | |||||||||||
| September 30, | September 30, | |||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||
| Revenue | $ | 2,661,660 | $ | 1,177,366 | $ | 7,343,791 | $ | 2,888,896 | ||||
| Cost of sales | 418,915 | 253,129 | 1,429,371 | 884,132 | ||||||||
| Gross profit | 2,242,745 | 924,237 | 5,914,420 | 2,004,764 | ||||||||
| Expenses | ||||||||||||
| Research and development | 296,124 | 468,533 | 1,475,437 | 1,996,715 | ||||||||
| General and administration | 444,859 | 592,539 | 2,308,846 | 2,307,368 | ||||||||
| Sales and marketing | 595,165 | 515,631 | 2,043,514 | 2,078,612 | ||||||||
| Depreciation and amortization | 678,313 | 714,131 | 2,755,882 | 3,010,263 | ||||||||
| 2,014,461 | 2,290,834 | 8,583,679 | 9,392,958 | |||||||||
| Income (loss) from continuing operations before other expenses | 228,284 | (1,366,597 | ) | (2,669,259 | ) | (7,388,194 | ) | |||||
| Other expenses | ||||||||||||
| Foreign exchange (gain) loss | 112,974 | (24,490 | ) | 169,815 | 78,793 | |||||||
| Finance (income) expense | (11,273 | ) | 223,650 | 1,014,779 | 354,720 | |||||||
| 101,701 | 199,160 | 1,184,594 | 433,513 | |||||||||
| Income (loss) from continuing operations before income taxes | 126,583 | (1,565,757 | ) | (3,853,853 | ) | (7,821,707 | ) | |||||
| Deferred income tax recovery | - | - | - | 162,797 | ||||||||
| Net income (loss) from continuing operations | 126,583 | (1,565,757 | ) | (3,853,853 | ) | (7,658,910 | ) | |||||
| Loss from discontinued operations | (427,277 | ) | (110,269 | ) | (900,279 | ) | (170,895 | ) | ||||
| Net loss | (300,694 | ) | (1,676,026 | ) | (4,754,132 | ) | (7,829,805 | ) | ||||
| Other comprehensive income (loss): | ||||||||||||
| Items that may be subsequently reclassified to earnings: | ||||||||||||
| Unrealized foreign exchange gain (loss) | ||||||||||||
| on translation of foreign operation | 61,890 | (14,258 | ) | 85,605 | 24,654 | |||||||
| Total comprehensive loss | $ | (238,804 | ) | $ | (1,690,284 | ) | $ | (4,668,527 | ) | $ | (7,805,151 | ) |
| Basic earnings (loss) per share: | ||||||||||||
| Continuing operations | $ | 0.00 | $ | (0.03 | ) | $ | (0.07 | ) | $ | (0.14 | ) | |
| Discontinued operations | $ | 0.00 | $ | 0.00 | $ | (0.01 | ) | $ | (0.01 | ) | ||
| Net loss | $ | 0.00 | $ | (0.03 | ) | $ | (0.08 | ) | $ | (0.15 | ) | |
| Diluted earnings (loss) per share: | ||||||||||||
| Continuing operations | $ | 0.00 | $ | (0.03 | ) | $ | (0.07 | ) | $ | (0.14 | ) | |
| Discontinued operations | $ | 0.00 | $ | 0.00 | $ | (0.01 | ) | $ | (0.01 | ) | ||
| Net loss | $ | 0.00 | $ | (0.03 | ) | $ | (0.08 | ) | $ | (0.15 | ) | |
| Weighted average number of common shares: | ||||||||||||
| Basic | 68,107,758 | 53,686,940 | 59,056,353 | 53,524,646 | ||||||||
| Diluted | 68,497,093 | 53,686,940 | 59,056,353 | 53,524,646 | ||||||||
| Nanotech Security Corp. | ||||||
| Condensed Consolidated Statements of Financial Position | ||||||
| as at September 30, 2017 and 2016 | ||||||
| (In Canadian dollars) | ||||||
| 2017 | 2016 | |||||
| Assets | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | $ | 10,883,919 | $ | 3,312,691 | ||
| Accounts receivable | 1,374,442 | 597,414 | ||||
| Inventory | 151,708 | 385,753 | ||||
| Prepaid expenses and other assets | 187,874 | 127,719 | ||||
| Assets held for sale | 216,225 | - | ||||
| 12,814,168 | 4,423,577 | |||||
| Property, plant and equipment | 15,856,998 | 17,338,312 | ||||
| Goodwill | 1,388,458 | 1,388,458 | ||||
| Intangible assets | - | 1,361,239 | ||||
| $ | 30,059,624 | $ | 24,511,586 | |||
| Liabilities and Shareholders' Equity | ||||||
| Current liabilities: | ||||||
| Accounts payable and accrued liabilities | $ | 1,431,466 | $ | 1,395,568 | ||
| Deferred revenue | 157,171 | - | ||||
| Liabilities directly associated with assets held for sale | 200,226 | - | ||||
| Note payable | - | 3,000,000 | ||||
| 1,788,863 | 4,395,568 | |||||
| Non-current liabilities: | ||||||
| Convertible debentures | - | 3,595,142 | ||||
| Tenant inducement | 71,223 | 98,793 | ||||
| 1,860,086 | 8,089,503 | |||||
| Shareholders’ equity | ||||||
| Share capital | 61,426,483 | 45,210,507 | ||||
| Contributed Surplus | 2,715,137 | 2,485,131 | ||||
| Deficit | (35,873,177 | ) | (31,119,045 | ) | ||
| Accumulated other comprehensive loss | (68,905 | ) | (154,510 | ) | ||
| 28,199,538 | 16,422,083 | |||||
| $ | 30,059,624 | $ | 24,511,586 | |||
| Nanotech Security Corp. | ||||||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||||
| Years ended September 30, 2017 and 2016 | ||||||||||||
| (in Canadian Dollars) | ||||||||||||
| Three months ended | Years ended | |||||||||||
| September 30, | September 30, | |||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||
| Cash flows provided by (used in): | ||||||||||||
| Operating activities: | ||||||||||||
| Net income (loss) from continuing operations | $ | 126,583 | $ | (1,565,757 | ) | $ | (3,853,853 | ) | $ | (7,658,910 | ) | |
| Items not involving cash: | ||||||||||||
| Depreciation and amortization | 729,030 | 768,766 | 2,917,883 | 3,077,997 | ||||||||
| Share-based compensation | 176,535 | 153,553 | 921,198 | 661,786 | ||||||||
| Accretion of convertible debentures | - | 71,969 | 589,858 | 80,825 | ||||||||
| Other | (6,892 | ) | (6,892 | ) | (27,570 | ) | (27,570 | ) | ||||
| Deferred income taxes | - | - | - | (162,797 | ) | |||||||
| Non-cash working capital changes | (394,605 | ) | (93,361 | ) | (720,420 | ) | 371,023 | |||||
| 630,651 | (671,722 | ) | (172,904 | ) | (3,657,646 | ) | ||||||
| Discontinued operations: | ||||||||||||
| Net loss from discontinued operations | (427,277 | ) | (110,269 | ) | (900,279 | ) | (170,895 | ) | ||||
| Depreciation | 3,214 | 6,487 | 12,804 | 17,689 | ||||||||
| Items not involving cash | 391,077 | (100,788 | ) | 313,162 | (91,976 | ) | ||||||
| Cash provided by (used in) operating activities | 597,665 | (876,292 | ) | (747,217 | ) | (3,902,828 | ) | |||||
| Investing activities: | ||||||||||||
| Purchase of property and equipment | (11,542 | ) | 12,933 | (106,944 | ) | (148,752 | ) | |||||
| Cash provided by (used in) investing activities | (11,542 | ) | 12,933 | (106,944 | ) | (148,752 | ) | |||||
| Financing activities: | ||||||||||||
| Issuance of shares for options exercised | - | 17,400 | 223,000 | 197,400 | ||||||||
| Proceeds on financing, net of costs | - | - | 12,486,784 | - | ||||||||
| Repayment of note payable | (3,000,000 | ) | - | (3,000,000 | ) | - | ||||||
| Repayment of convertible debentures | - | - | (1,370,000 | ) | - | |||||||
| Proceeds on issuance of convertible debenture, net of costs | - | - | - | 4,120,289 | ||||||||
| Cash provided by (used in) financing activities | (3,000,000 | ) | 17,400 | 8,339,784 | 4,317,689 | |||||||
| Effect of foreign exchange on cash and cash equivalents | 61,890 | (14,258 | ) | 85,605 | 24,654 | |||||||
| Increase (decrease) in cash and cash equivalents | (2,351,987 | ) | (860,217 | ) | 7,571,228 | 290,763 | ||||||
| Cash and cash equivalents, beginning of year | 13,235,906 | 4,172,908 | 3,312,691 | 3,021,928 | ||||||||
| Cash and cash equivalents, end of year | $ | 10,883,919 | $ | 3,312,691 | $ | 10,883,919 | $ | 3,312,691 | ||||
Conference Call Details:
DATE: | Thursday, December 21, 2017 | Time: 5:00 PM Eastern Standard Time |
DIAL IN NUMBER: | Toll free (Canada and US): 1-866-548-4713 Conference ID: 2567584 | Alternate number: 1-323-794-2093 |
TAPED REPLAY: | Toll free (Canada and US): 1-844-512-2921 Replay available until January 21, 2018 Replay Pin number: 2567584 | Alternate number: 1-412-317-6671 Replay Pin number: 2567584 |
WEBCAST: | http://public.viavid.com/index.php?id=127618 |
FORWARD-LOOKING STATEMENTS
The discussion and analysis in this news release contains forward-looking statements concerning anticipated developments in the Company’s operations in future periods, the adequacy of Nanotech’s financial resources, and the events or conditions that may occur in the future. Forward-looking statements are frequently, but not always, identified by words such as “expects”, “anticipates”, “believes”, “intends”, “estimates”, “predicts”, “potential”, “targeted” “plans”, “possible” and similar expressions, or statements that events, conditions, or results “will”, “may”, “could” or “should” occur or be achieved.
These forward-looking statements include, without limitation, statements about the Company’s market opportunities, strategies, competition, and the Company’s views that its optics based technologies will continue to show promise for large scale production. Other forward-looking statements imply that the Company will remain capable of being financed and/or will be able to partner development until profitability is eventually realized. The principal risks related to these forward-looking statements are that the Company’s products receive market acceptance, that its intellectual property claims will be sufficiently broad or enforceable to provide the necessary protection or attract the necessary capital.
These forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made. Consequently, all forward-looking statements made in the discussion and analysis of the financial conditions and results of operations or the documents incorporated by reference, are qualified by this cautionary statement and there can be no certainty that actual results or developments the Company anticipates will be realized. For additional information with respect to certain of these risks or factors reference should be made to the “Business Risks and Uncertainties” section of the management’s discussion and analysis and notes to the consolidated financial statements, as well as with the Company’s continuous disclosure materials filed from time to time with Canadian securities regulatory authorities, which are available online at www.sedar.com. Nanotech disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law. Caution needs to be used when taking forward-looking statements into account when evaluating the Company.
About Nanotech Security
Nanotech designs, manufactures and markets nano-optic products that have brand protection and enhancement applications across a wide range of markets including banknotes, tax stamps, secure government documents, commercial branding, and the pharmaceutical industry.
The Company’s nano-optic technology employs arrays of billions of nano-indentations that are impressed or embossed onto a substrate material such as polymer, paper, metal, or fabric. By using sophisticated algorithms to direct an electron beam, the Company creates visual images with colour shifting effects such as 3D, perceived movement, and can also display high-definition colours including skin tones, and whites and blacks, which are not possible using holographic technology.
Additional information about Nanotech can be found at the Company’s website www.nanosecurity.ca, the Canadian disclosure filings website www.sedar.com or the OTCMarkets disclosure filings website www.otcmarkets.com.
| Nanotech Security Corp: | Canada Investor Relations: | U.S. Investor Relations: | |
| Doug Blakeway | Sean Peasgood | Matthew Selinger | |
| info@nanosecurity.ca | sean@SophicCapital.com | mselinger@threepa.com | |
| +1.416.565.2805 | +1.817.310.8776 | ||
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.